CLINICAL_TRIALS
trial_result
· 2010-04-12
Clinical Trial Update: A Long-term Safety Study of Once-daily Travatan [Phase 3]
Summary
Long-term safety results from a Phase 3 study evaluating once-daily Travatan (latanoprost) in open-angle glaucoma and ocular hypertension.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Alcon Research | Conditions: Glaucoma, Open-angle, Ocular Hypertension | Phase 3 | Status: COMPLETED | Results posted: 2010-04-12